HRES 672
106th Congress
House
Expressing the sense of the House of Representatives that the private-sector distributors of the influenza vaccine should give priority to distributing the available vaccine to those people at a high…
Official title: Expressing the sense of the House of Representatives that the private-sector distributors of the influenza vaccine should give priority to distributing the ava… Show full official titleShow less
Official title: Expressing the sense of the House of Representatives that the private-sector distributors of the influenza vaccine should give priority to distributing the available vaccine to those people at a high risk of developing complications from an influenza infection.
Everywhere this bill has been
1 steps
Introduced
In committee
Reported out
Agreed to (House)
Dec 13, 2000
Referred to the Subcommittee on Health and Environment.
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Latest action
Referred to the Subcommittee on Health and Environment.
Committees of jurisdiction
1
Cite this page
U.S. Congress. (2026). H. Res. 672: Expressing the sense of the House of Representatives that the private-sector distributors of the influenza vaccine should give priority to distributing the available vaccine to those people at a high risk of developing complications from an influenza infection.. 106th Congress. Open America. https://openamerica.io/bill/106-HRES-672/
"H. Res. 672: Expressing the sense of the House of Representatives that the private-sector distributors of the influenza vaccine should give priority to distributing the available vaccine to those people at a high risk of developing complications from an influenza infection.." 106th Congress, 2026, Open America, https://openamerica.io/bill/106-HRES-672/.
H. Res. 672, 106th Cong. (2026), https://openamerica.io/bill/106-HRES-672/.
[H. Res. 672: Expressing the sense of the House of Representatives that the private-sector distributors of the influenza vaccine should give priority to distributing the available vaccine to those people at a high risk of developing complications from an influenza infection.](https://openamerica.io/bill/106-HRES-672/)